stock price decline

POET Technologies stock plummets 47% after Marvell cancels orders citing confidentiality violations; class action lawsuit filed against company.

Portnoy Law Firm sues Globant on behalf of investors over alleged misrepresentation of Latin American pivot, citing hidden operational failures and workforce cuts.

SES AI stock crashes 37% to $1.08 after securities fraud probe launched over alleged concealment of customer losses and questionable acquisition.

Class action lawsuit filed against $GLOB alleging material misstatements about Latin American demand weakness, frozen wages, and project cancellations. Stock crashed 27.8% in February 2025.

Class action lawsuit filed against $GLOB alleges materially false statements regarding Latin America business challenges. Stock plummeted 27.8% in February 2025 after missed guidance.

ImmunityBio faces class action lawsuit after FDA warning letter over false cancer claims by Executive Chairman Patrick Soon-Shiong. Stock plunged 21%.

LKQ Corporation faces class action securities fraud lawsuit over FinishMaster acquisition misrepresentations. Stock plunged 17.8% after July 2025 earnings miss. Lead plaintiff deadline: June 22, 2026.

Gossamer Bio ($GOSS) faces class action lawsuit after Phase 3 trial failure caused 80% stock plunge. Investors allege management misled them about trial design despite knowing of critical issues.

ImmunityBio (IBRX) shares plunged 21% after FDA warning letter citing misleading efficacy claims about immunotherapy drug Anktiva. Class action lawsuit underway with May 26 deadline.

Pomerantz LLP investigates CarMax for potential securities fraud after stock fell 15% following April earnings announcement and pricing strategy shift.

Pomerantz LLP investigates Byrna Technologies for potential securities fraud after April earnings revealed deteriorating online sales, conversion rates, and order values, triggering steep stock decline.

Pomerantz Law Firm investigates Veritone after accounting errors reduced Q3 2025 revenue by $2.48M. Stock plunged 8.33% to $2.09 on disclosure.

Pomerantz LLP investigates $BMI following massive earnings miss and 24% stock collapse. Revenue fell short by $28.58M; utility water sales declined 10% YoY.

Pomerantz LLP investigates Nano-X Imaging for potential securities fraud following $33.4M Q4 2025 loss, $17.5M asset impairment, and CFO departure, triggering 24.39% stock decline.

Pomerantz Law Firm files class action lawsuit against Hercules Capital ($HTGC) alleging securities fraud following damaging short report. Investors can claim lead plaintiff status until May 19, 2026.

Pomerantz LLP investigates $DERM for potential securities fraud after revealing prescription-revenue disconnect tied to reimbursement timing issues.

Pomerantz Law Firm investigates potential securities fraud at $BTGO following 68% stock plunge after company reported $14.8M loss versus $156.6M profit prior year.

Camping World stock plummets 41% following Q3-Q4 losses; class action lawsuit alleges securities fraud. Investors have until May 11, 2026 to seek Lead Plaintiff status.

Pomerantz Law Firm files class action against $ATRA over alleged misstatements regarding tabelecleucel's regulatory prospects, following FDA rejections and severe stock declines.

Pomerantz LLP sues ODDITY Tech ($ODD) alleging executives concealed partner algorithm changes that inflated customer acquisition costs, leading to undisclosed 30% revenue decline and 49% stock crash.